A E Barber Selected Research

Matrix Metalloproteinase Inhibitors

9/2000	Matrix metalloproteinase inhibition protects hepatic integrity in hemorrhagic shock.
5/2000	Hepatic integrity dependent on matrix metalloproteinase inhibition, not tumor necrosis factor alpha or different bleeding rates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A E Barber Research Topics

Disease

3	Hemorrhagic Shock 05/2001 - 05/2000
2	Neoplasms (Cancer) 12/2012 - 03/2004
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2004
1	Hemorrhage 05/2000

Drug/Important Bio-Agent (IBA)

2	Interleukin-6 (Interleukin 6)IBA 05/2001 - 09/2000
2	Matrix Metalloproteinase InhibitorsIBA 09/2000 - 05/2000
2	Matrix Metalloproteinases (MMPs)IBA 09/2000 - 05/2000
2	CytokinesIBA 09/2000 - 05/2000
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2000 - 05/2000
1	Pharmaceutical PreparationsIBA 12/2012
1	Leucine (L-Leucine)FDA Link 03/2004
1	Amino Acids FDA Link 03/2004
1	Arginine (L-Arginine)FDA Link 03/2004
1	Glutamine (L-Glutamine)FDA Link 03/2004
1	beta-hydroxyisovaleric acid (beta-hydroxy-beta-methylbutyrate)IBA 03/2004
1	ADAM17 ProteinIBA 05/2000

Therapy/Procedure

1	Resuscitation 05/2001